A new Kaiser Foundation poll shows that while there is broad bipartisan support among voters for either making drug makers disclose how they set prices or letting Medicare negotiate prices, a majority of people, and 76 percent of Republicans, say they prefer market competition over government regulation to control drug prices. The drug industry says Medicare price negotiation is tantamount to the government setting prices and notes that private Medicare drug plans already negotiate prices with drug makers. A Kaiser...